Skip to main content
Log in

Seven gene testing for risk of breast cancer cost effective

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2015 US dollars

Reference

  • Li Y, et al. A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer. Value in Health : 13 Mar 2017. Available from: URL: http://dx.doi.org/10.1016/j.jval.2017.01.006

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Seven gene testing for risk of breast cancer cost effective. PharmacoEcon Outcomes News 774, 24 (2017). https://doi.org/10.1007/s40274-017-3848-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-3848-4

Navigation